Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Valneva
Pharma
FDA, CDC call for pause of chikungunya shot rollout in seniors
On the heels of similar moves in Europe, U.S. health authorities are calling for a pause in the use of Valneva’s chikungunya vaccine in older adults.
Fraiser Kansteiner
May 12, 2025 9:52am
France suspends use of Valneva chikungunya shot in older adults
Apr 28, 2025 10:35am
Bavarian Nordic's chikungunya vaccine wins broad FDA approval
Feb 18, 2025 4:45pm
Valneva nabs $33M US supply pact for Japanese encephalitis shot
Feb 3, 2025 11:32am
Valneva rallies behind launch of its new chikungunya vaccine
Apr 18, 2024 12:02pm
FDA signs off on Valneva's chikungunya vaccine Ixchiq
Nov 10, 2023 9:55am
